+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biotechnology & Pharmaceutical Services Outsourcing Market by Service Type, Mode of Outsourcing, Company Size, Therapeutic Area, Service Provider Type - Global Forecast 2025-2030- Product Image
Biotechnology & Pharmaceutical Services Outsourcing Market by Service Type, Mode of Outsourcing, Company Size, Therapeutic Area, Service Provider Type - Global Forecast 2025-2030- Product Image
Sale

Biotechnology & Pharmaceutical Services Outsourcing Market by Service Type, Mode of Outsourcing, Company Size, Therapeutic Area, Service Provider Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010907
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The biotechnology and pharmaceutical services outsourcing market is rapidly adapting to an evolving global landscape driven by digital transformation, regulatory complexity, and changing supply chain priorities. Senior executives navigating this environment require focused insights to inform investment, risk mitigation, and strategic partnerships for lasting business value.

Market Snapshot: Biotechnology & Pharmaceutical Services Outsourcing

The biotechnology and pharmaceutical services outsourcing market grew from USD 55.42 billion in 2024 to USD 58.54 billion in 2025. It is forecast to advance at a CAGR of 5.71%, reaching USD 77.38 billion by 2030.

Scope & Segmentation

  • Service Types: Clinical trial services (Phases I-IV); consulting services (M&A advisory, market access, portfolio management, strategic consulting); manufacturing services (API production, CDMO, fill-finish, formulation development, packaging, tech transfer); preclinical services (animal studies, bioanalytical testing, DMPK, pharmacology, toxicology); quality management; regulatory affairs (agency representation, dossier preparation, safety, labeling compliance, submission strategy); research and development services (assay development, biomarker discovery, lead identification/optimization, target validation); pharmacovigilance.
  • Mode of Outsourcing: Full-service outsourcing; functional service provider (FSP) model; tactical/project-based outsourcing.
  • Company Size: Large enterprises; small and medium enterprises (SMEs).
  • Therapeutic Areas: Oncology, immunology, infectious diseases, rare diseases, cardiovascular, dermatology, gastroenterology, metabolic disorders, neurology, pediatrics, respiratory.
  • Service Provider Types: Consulting firms, CDMOs, CMOs, CROs, regulatory affairs firms, data management & IT service providers.
  • Regional Coverage: Americas (including US, Canada, Mexico, Brazil, Argentina), EMEA (United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Notable Companies Profiled: AmerisourceBergen Corporation, Catalent, Inc., Charles River Laboratories, Curia Global, Eurofins Scientific, Icon PLC, IQVIA HOLDINGS, INC., Parexel, Syneos Health, Thermo Fisher Scientific, WuXi AppTec, among others.

Key Takeaways: Strategic Insights for Decision Makers

  • Outsourcing is fundamental for companies aiming to drive operational efficiency, accelerate timelines, and control costs while managing regulatory and supply chain complexity.
  • Demand for digital solutions is rising as artificial intelligence, cloud platforms, and remote monitoring enhance trial management and streamline collaboration.
  • Precision medicine and specialty therapeutic areas require partners with advanced scientific capabilities in areas like biomarker discovery, assay development, and targeted validation.
  • Service providers are expanding their offerings with integrated solutions and joint ventures to simplify vendor management and address sponsor demands for end-to-end capabilities.
  • Regulatory harmonization is prompting deeper expertise in compliance, safety monitoring, and submission strategy for successful global approvals.
  • Environmental sustainability and resilient supply chains are becoming essential evaluation criteria, especially in response to shifting trade and geopolitical pressures.

Tariff Impact: Navigating Trade Policy Changes

New United States tariff policies implemented in 2025 are reshaping biopharma and biotechnology outsourcing strategies by increasing production costs, influencing sourcing decisions, and prompting a move toward regional supply hubs. Joint ventures, flexible contracting models, and greater emphasis on digital procurement are facilitating risk sharing and cost management. Organizations are prioritizing geographic diversification and digital supply chain tools to strengthen continuity amid evolving trade realities.

Methodology & Data Sources

This research integrates primary interviews with industry thought leaders, executives, and experts, alongside secondary analysis of industry publications, regulatory documents, and company reports. Triangulation techniques and multiple internal reviews ensure robust, actionable, and validated market intelligence.

Why This Report Matters for Outsourcing Decision-Makers

  • Enables executives to pinpoint high-growth outsourcing segments, align investment with strategic priorities, and respond proactively to regulatory and digital disruption.
  • Provides a structured roadmap for evaluating potential partners, navigating supply chain risks, and incorporating best practices in environmental and operational sustainability.

Conclusion

Senior leaders can leverage these insights to sharpen competitive positioning, foster resilient supply chains, and advance innovation through strategic outsourcing. The report serves as a practical tool for prioritizing investments and optimizing partnerships in the evolving biotechnology services landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid adoption of artificial intelligence platforms enabling accelerated drug discovery in contract research services
5.2. Growing demand for personalized medicine leading to expansion of specialized outsourcing solutions
5.3. Surge in cell and gene therapy outsourcing requiring specialized manufacturing capacity expansions
5.4. Integration of sustainability and green chemistry practices in pharmaceutical outsourcing operations
5.5. Expanding role of real world evidence and data analytics in shaping outsourcing clinical trial strategies
5.6. Consolidation among CDMOs driving strategic partnerships and capacity optimization in biomanufacturing services
5.7. Regulatory harmonization initiatives influencing global outsourcing of clinical trials and drug approvals
5.8. Increased focus on risk mitigation and supply chain resilience in pharmaceutical service outsourcing agreements
5.9. Emergence of digital patient engagement tools transforming site management and remote monitoring in clinical trials
5.10. Adoption of continuous manufacturing processes accelerating biologics production in outsourced contract facilities
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biotechnology & Pharmaceutical Services Outsourcing Market, by Service Type
8.1. Introduction
8.2. Clinical Trial Services
8.2.1. Phase I
8.2.2. Phase II
8.2.3. Phase III
8.2.4. Phase IV
8.3. Consulting Services
8.3.1. M&A Advisory
8.3.2. Market Access & Reimbursement Consulting
8.3.3. Portfolio Management
8.3.4. Strategic Consulting
8.4. Manufacturing Services
8.4.1. API Production
8.4.2. Contract Development & Manufacturing Organization (CDMO) Services
8.4.3. Fill-Finish Services
8.4.4. Formulation Development
8.4.5. Packaging & Labeling
8.4.6. Scale-Up & Tech Transfer
8.5. Pharmacovigilance Services
8.6. Preclinical Services
8.6.1. Animal Studies
8.6.2. Bioanalytical Testing
8.6.3. DMPK Studies
8.6.4. Pharmacology Studies
8.6.5. Toxicology Testing
8.7. Quality Management Services
8.8. Regulatory Affairs Services
8.8.1. Agency Communication & Representation
8.8.2. Dossier Preparation
8.8.3. Labeling & Packaging Compliance
8.8.4. Pharmacovigilance & Safety Monitoring
8.8.5. Regulatory Strategy & Submissions
8.9. Research & Development Services
8.9.1. Assay Development
8.9.2. Biomarker Discovery
8.9.3. Lead Identification & Optimization
8.9.4. Target Validation
9. Biotechnology & Pharmaceutical Services Outsourcing Market, by Mode of Outsourcing
9.1. Introduction
9.2. Full-Service Outsourcing
9.3. Functional Service Provider (FSP) Model
9.4. Tactical/Project-Based Outsourcing
10. Biotechnology & Pharmaceutical Services Outsourcing Market, by Company Size
10.1. Introduction
10.2. Large Enterprises
10.3. Small & Medium Enterprises (SMEs)
11. Biotechnology & Pharmaceutical Services Outsourcing Market, by Therapeutic Area
11.1. Introduction
11.2. Cardiovascular
11.3. Dermatology
11.4. Gastroenterology
11.5. Immunology
11.6. Infectious Diseases
11.7. Metabolic Disorders
11.8. Neurology
11.9. Oncology
11.10. Pediatrics
11.11. Rare Diseases
11.12. Respiratory
12. Biotechnology & Pharmaceutical Services Outsourcing Market, by Service Provider Type
12.1. Introduction
12.2. Consulting Firms
12.3. Contract Development & Manufacturing Organizations (CDMOs)
12.4. Contract Manufacturing Organizations (CMOs)
12.5. Contract Research Organizations (CROs)
12.6. Data Management & IT Service Providers
12.7. Regulatory Affairs Firms
13. Americas Biotechnology & Pharmaceutical Services Outsourcing Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Biotechnology & Pharmaceutical Services Outsourcing Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Biotechnology & Pharmaceutical Services Outsourcing Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. AmerisourceBergen Corporation
16.3.2. Catalent, Inc.
16.3.3. CEVA Logistics AG
16.3.4. Charles River Laboratories, Inc.
16.3.5. Concept Heidelberg GmbH
16.3.6. Curia Global, Inc.
16.3.7. Dalton Pharma Services by Seikagaku Corporation
16.3.8. DHL International GmbH
16.3.9. Eurofins Scientific (Ireland) Limited
16.3.10. Evotec SE
16.3.11. GenScript Biotech Corporation
16.3.12. Icon PLC
16.3.13. IQVIA HOLDINGS, INC.
16.3.14. Laboratory Corporation of America Holdings
16.3.15. Lachman Consultant Services, Inc.
16.3.16. McKesson Corporation by Aurelius Group
16.3.17. Medpace Holdings, Inc.
16.3.18. Parexel International Corporation
16.3.19. Syneos Health, Inc.
16.3.20. Thermo Fisher Scientific Inc.
16.3.21. WuXi AppTec Co., Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY MODE OF OUTSOURCING, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY MODE OF OUTSOURCING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COMPANY SIZE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COMPANY SIZE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET: RESEARCHAI
FIGURE 26. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET: RESEARCHSTATISTICS
FIGURE 27. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET: RESEARCHCONTACTS
FIGURE 28. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL TRIAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL TRIAL SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHASE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHASE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHASE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHASE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHASE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHASE IV, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHASE IV, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL TRIAL SERVICES, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL TRIAL SERVICES, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY M&A ADVISORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY M&A ADVISORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY MARKET ACCESS & REIMBURSEMENT CONSULTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY MARKET ACCESS & REIMBURSEMENT CONSULTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PORTFOLIO MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PORTFOLIO MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY STRATEGIC CONSULTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY STRATEGIC CONSULTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING SERVICES, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING SERVICES, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY MANUFACTURING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY MANUFACTURING SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY API PRODUCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY API PRODUCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION (CDMO) SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION (CDMO) SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY FILL-FINISH SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY FILL-FINISH SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY FORMULATION DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY FORMULATION DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PACKAGING & LABELING, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PACKAGING & LABELING, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SCALE-UP & TECH TRANSFER, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SCALE-UP & TECH TRANSFER, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY ANIMAL STUDIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY ANIMAL STUDIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY DMPK STUDIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY DMPK STUDIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMACOLOGY STUDIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMACOLOGY STUDIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL SERVICES, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY QUALITY MANAGEMENT SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY QUALITY MANAGEMENT SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY AGENCY COMMUNICATION & REPRESENTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY AGENCY COMMUNICATION & REPRESENTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY DOSSIER PREPARATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY DOSSIER PREPARATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY LABELING & PACKAGING COMPLIANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY LABELING & PACKAGING COMPLIANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE & SAFETY MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE & SAFETY MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY STRATEGY & SUBMISSIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY STRATEGY & SUBMISSIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS SERVICES, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS SERVICES, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY RESEARCH & DEVELOPMENT SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY RESEARCH & DEVELOPMENT SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY ASSAY DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY ASSAY DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY LEAD IDENTIFICATION & OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY LEAD IDENTIFICATION & OPTIMIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY RESEARCH & DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY RESEARCH & DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY MODE OF OUTSOURCING, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY MODE OF OUTSOURCING, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY FULL-SERVICE OUTSOURCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY FULL-SERVICE OUTSOURCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY FUNCTIONAL SERVICE PROVIDER (FSP) MODEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY FUNCTIONAL SERVICE PROVIDER (FSP) MODEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY TACTICAL/PROJECT-BASED OUTSOURCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY TACTICAL/PROJECT-BASED OUTSOURCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COMPANY SIZE, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COMPANY SIZE, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY LARGE ENTERPRISES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY LARGE ENTERPRISES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SMALL & MEDIUM ENTERPRISES (SMES), BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SMALL & MEDIUM ENTERPRISES (SMES), BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY DERMATOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY RARE DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY RESPIRATORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER TYPE, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER TYPE, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING FIRMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING FIRMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS (CDMOS), BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS (CDMOS), BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS (CMOS), BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS (CMOS), BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY DATA MANAGEMENT & IT SERVICE PROVIDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY DATA MANAGEMENT & IT SERVICE PROVIDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS FIRMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS FIRMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL TRIAL SERVICES, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL TRIAL SERVICES, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING SERVICES, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING SERVICES, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL SERVICES, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS SERVICES, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS SERVICES, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY RESEARCH & DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY RESEARCH & DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY MODE OF OUTSOURCING, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY MODE OF OUTSOURCING, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COMPANY SIZE, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COMPANY SIZE, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER TYPE, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER TYPE, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL TRIAL SERVICES, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL TRIAL SERVICES, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING SERVICES, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING SERVICES, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL SERVICES, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS SERVICES, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS SERVICES, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY RESEARCH & DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY RESEARCH & DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY MODE OF OUTSOURCING, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY MODE OF OUTSOURCING, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COMPANY SIZE, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COMPANY SIZE, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER TYPE, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER TYPE, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 195. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 196. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 197. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL TRIAL SERVICES, 2018-2024 (USD MILLION)
TABLE 198. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL TRIAL SERVICES, 2025-2030 (USD MILLION)
TABLE 199. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING SERVICES, 2018-2024 (USD MILLION)
TABLE 200. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING SERVICES, 2025-2030 (USD MILLION)
TABLE 201. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 202. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 203. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2024 (USD MILLION)
TABLE 204. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL SERVICES, 2025-2030 (USD MILLION)
TABLE 205. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS SERVICES, 2018-2024 (USD MILLION)
TABLE 206. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS SERVICES, 2025-2030 (USD MILLION)
TABLE 207. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY RESEARCH & DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 208. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY RESEARCH & DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 209. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY MODE OF OUTSOURCING, 2018-2024 (USD MILLION)
TABLE 210. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY MODE OF OUTSOURCING, 2025-2030 (USD MILLION)
TABLE 211. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COMPANY SIZE, 2018-2024 (USD MILLION)
TABLE 212. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COMPANY SIZE, 2025-2030 (USD MILLION)
TABLE 213. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 214. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 215. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER TYPE, 2018-2024 (USD MILLION)
TABLE 216. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER TYPE, 2025-2030 (USD MILLION)
TABLE 217. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 218. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 219. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL TRIAL SERVICES, 2018-2024 (USD MILLION)
TABLE 220. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL TRIAL SERVICES, 2025-2030 (USD MILLION)
TABLE 221. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING SERVICES, 2018-2024 (USD MILLION)
TABLE 222. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING SERVICES, 2025-2030 (USD MILLION)
TABLE 223. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 224. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 225. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2024 (USD MILLION)
TABLE 226. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRECLINICAL SERVICES, 2025-2030 (USD MILLION)
TABLE 227. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS SERVICES, 2018-2024 (USD MILLION)
TABLE 228. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS SERVICES, 2025-2030 (USD MILLION)
TABLE 229. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY RESEARCH & DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 230. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY RESEARCH & DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 231. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY MODE OF OUTSOURCING, 2018-2024 (USD MILLION)
TABLE 232. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY MODE OF OUTSOURCING, 2025-2030 (USD MILLION)
TABLE 233. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COMPANY SIZE, 2018-2024 (USD MILLION)
TABLE 234. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COMPANY SIZE, 2025-2030 (USD MILLION)
TABLE 235. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 236. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 237. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER TYPE, 2018-2024 (USD MILLION)
TABLE 238. MEXICO BIOTECHNOLOGY & P

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Biotechnology & Pharmaceutical Services Outsourcing market report include:
  • AmerisourceBergen Corporation
  • Catalent, Inc.
  • CEVA Logistics AG
  • Charles River Laboratories, Inc.
  • Concept Heidelberg GmbH
  • Curia Global, Inc.
  • Dalton Pharma Services by Seikagaku Corporation
  • DHL International GmbH
  • Eurofins Scientific (Ireland) Limited
  • Evotec SE
  • GenScript Biotech Corporation
  • Icon PLC
  • IQVIA HOLDINGS, INC.
  • Laboratory Corporation of America Holdings
  • Lachman Consultant Services, Inc.
  • McKesson Corporation by Aurelius Group
  • Medpace Holdings, Inc.
  • Parexel International Corporation
  • Syneos Health, Inc.
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages184
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 58.54 Billion
Forecasted Market Value ( USD ) by 2030 $ 77.38 Billion
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Pharmaceutical Services Outsourcing Market by Service Type (Clinical Development, Data Management, Manufacturing Services), Clinical Phase (Phase I, Phase II, Phase III), Customer Type, Contract Model, Therapeutic Area - Global Forecast 2025-2030 - Product Image

Pharmaceutical Services Outsourcing Market by Service Type (Clinical Development, Data Management, Manufacturing Services), Clinical Phase (Phase I, Phase II, Phase III), Customer Type, Contract Model, Therapeutic Area - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Biotechnology / Pharmaceutical Services Outsourcing - Global Strategic Business Report - Product Image

Biotechnology / Pharmaceutical Services Outsourcing - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Pharmaceutical Analytical Testing Outsourcing Market by Service Type, Technology, Molecule Type, Application, End User, Project Duration - Global Forecast 2025-2030 - Product Image

Pharmaceutical Analytical Testing Outsourcing Market by Service Type, Technology, Molecule Type, Application, End User, Project Duration - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Small Molecule Innovator API CDMO Market Size, Share & Trends Analysis Report By Stage Type (Preclinical, Clinical, Commercial), By Customer Type (Pharmaceutical, Biotechnology), By Therapeutic Area, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Small Molecule Innovator API CDMO Market Size, Share & Trends Analysis Report By Stage Type (Preclinical, Clinical, Commercial), By Customer Type (Pharmaceutical, Biotechnology), By Therapeutic Area, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Chemistry, Manufacturing And Control Services Outsourcing Market Size, Share & Trends Analysis Report By Type, By Service, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Chemistry, Manufacturing And Control Services Outsourcing Market Size, Share & Trends Analysis Report By Type, By Service, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.